Uncontrolled Lower Respiratory Symptoms in the World Trade Center Survivor Program
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 27 May 2019
Price : $35 *
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Respiratory tract disorders
- Focus Therapeutic Use
- 25 Jan 2019 Planned End Date changed from 1 Sep 2018 to 1 Aug 2019.
- 25 Jan 2019 Planned primary completion date changed from 1 Sep 2018 to 1 Aug 2019.
- 25 Jan 2019 Status changed from recruiting to active, no longer recruiting.